Hepatocyte-specific Pten-deficient mouse
Liver-specific Pten deficiency driven by albumin promoter leads to steatosis that progresses to a NASH-like stage characterized by inflammation and fibrosis before eventually developing liver tumors; tumors were present in 66% of males and 30% of females at 40-44 weeks, with HCC reaching 83% in males and 50% in females at 74-78 weeks.
结局指标
获得可供光学显微镜观察的 H&E 染色组织切片:细胞核蓝紫色、细胞质与结缔组织纤维粉红色,用于观察组织中细胞的整体结构与形态细节。本方案本身不产出病理评分数值,也不提供特定分子标志物的定量结果。
实验动物
- 年龄
- as reported in cited studies
- 组织
- liver
实验步骤
脱蜡(Dewaxing) 石蜡切片置于二甲苯中脱蜡 3 次,每次 00:03:00。 复水(Rehydration) 石蜡切片依次置于 100% 乙醇中 3 次、每次 00:03:00,再置于 95% 乙醇中 1 次、00:03:00,随后用水漂洗。 苏木素核染色(Hematoxylin staining) 石蜡切片以苏木素染液染色 00:00:20,随后在流水下冲洗 00:01:00。 分化与返蓝(Differentiation and bluing) 石蜡切片置于返蓝液中 00:01:00,随后在流水下冲洗 00:01:00;此步使细胞核呈现蓝色。 伊红染色(Eosin staining) 石蜡切片以伊红复染 00:00:10;此步使细胞质成分与结缔组织纤维呈现粉红色。 脱水与透明(Dehydration and Clearing) 石蜡切片依次置于 95% 乙醇中 00:02:00、100% 乙醇中 2 次、每次 00:02:00,随后置于二甲苯中 2 次、每次 00:02:00。 封片(Mounting) 石蜡切片以 Permount 封片介质加盖玻片封固。
模型身份
- 模型名称
- Hepatocyte-specific Pten-deficient mouse
- 物种
- mouse
- NCBI Taxonomy ID
- 10090
- 基因型/合子状态
- Hepatocyte-specific Pten null (Albumin-Cre; Pten floxed)
生物学特性
- 表型出现阶段
- Steatosis is established early; steatohepatitis-like inflammation and fibrosis emerge around 10 weeks of age; hepatic tumors appear at 40-44 weeks and HCC by 74-78 weeks.
- 适用研究问题
- Used to model the natural progression of NAFLD to NASH and NASH-associated hepatocellular carcinoma in a spontaneous genetic model; evaluates interventions that modify progression from steatohepatitis to HCC.
- 模型局限
- The evidence adopted here for hepatocyte-specific Pten deficiency comes from review recommendations rather than from direct use of the model in the primary studies of this package; hepatocyte-specific Pten deficiency is a purely genetic model and does not reproduce the metabolic etiology of human NAFLD (no obesity or insulin resistance); the original studies used mixed genetic backgrounds and the precise Cre construct details and substrain composition are not reported in the sources adopted here.
实验方法
实验方案
- Hematoxylin and Eosin (H&E) staining for histopathology
本方案用于固定、石蜡包埋组织切片(4 μm)的苏木素-伊红(H&E)染色:经脱蜡、复水、苏木素核染、返蓝、伊红复染、脱水透明与封片七个步骤,使细胞核呈蓝紫色、细胞质与结缔组织纤维呈粉红色,供光学显微镜下观察组织中细胞与整体结构形态。
配套试剂与材料
- 组织学二甲苯(混合异构体)
脱蜡剂
- Ethanol
复水梯度溶剂(去除二甲苯)
- 95% 乙醇溶液
复水梯度溶剂
- 自来水(组织学染色用)
复水后漂洗用水(后续各流水冲洗共用)
- Epredia Signature Series 苏木素染液(7221)
细胞核染色
- Epredia Signature Series 返蓝液(7301)
返蓝(使细胞核转蓝)
- Epredia Signature Series 伊红 Y 染液(7111)
细胞质与结缔组织纤维复染
- Permount 组织学封片剂(Fisher SP15)
封片介质
参考文献
- Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Riordan Jesse D; Nadeau Joseph H Mammalian genome : official journal of the International Mammalian Genome Society 2014.
- Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Wu Jian Oncotarget 2016.
- Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. Lau Jennie Ka Ching; Zhang Xiang; Yu Jun The Journal of pathology 2017.
- Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma. Takakura Kazuki; Oikawa Tsunekazu; Tomita Yoichi; et al. World journal of gastroenterology 2018.
- Nathalia L. Oliveira; Samantha Gruenheid. Hematoxylin and Eosin (H&E) staining for histopathology. protocols.io, v1, 2026-07-31. DOI: 10.17504/protocols.io.kxygxr9jdg8j
- Epredia Signature Series Hematoxylin (7221), 产品信息页, Fisher Scientific
- Epredia Signature Series Bluing Reagent (7301), 产品信息页, Fisher Scientific
- Epredia Signature Series Eosin Y (7111), 产品信息页, Fisher Scientific
- Xylene, Fisherbrand HistoPrep (HC7001GAL), 产品信息页, Fisher Scientific
- Fisher Chemical Permount Mounting Medium (SP15 产品族), 产品信息页, Fisher Scientific
- Ethanol (CID 702, CAS 64-17-5), PubChem 化合物标准记录
- ARRIVE 2.0 官方规范